Figure 2 | Scientific Reports

Figure 2

From: Recombinant pre-miR-29b for Alzheimer´s disease therapeutics

Figure 2

Recombinant pre-miR-29b effect on BACE1 levels in N2a695 cells at different concentrations of the pre-miR-29b for 72 h.

(A) Representative confocal microscopy images of N2a695 cells treated with CS/pre-miR-29b, PEI/pre-miR-29b and Lipo/pre-miR-29b stained against BACE1. Quantification of fluorescence intensity for BACE1 protein expression in cells transfected with: (B) CS/pre-miR-29b, (C) PEI/pre-miR-29b and (D) Lipo/pre-miR-29b. All results are expressed relatively to those in untreated cells and error bars represent standard deviations derived from three or more independent experiments performed in triplicate. ANOVA, mean ± SD.

Back to article page